Nkarta (NKTX) Profit After Tax (2019 - 2026)
Nkarta (NKTX) recorded quarterly Profit After Tax of -$27.8 million in Q1 2026, down 1.54% quarter-over-quarter from -$27.4 million in Q4 2025, and up 12.98% on a YoY basis from -$24.6 million in Q1 2025.
Nkarta (NKTX) Profit After Tax (2019 - 2026) Analysis & Trends
Nkarta's Profit After Tax history runs 8 years deep, the most recent figure standing at -$27.8 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 12.98% year-over-year to -$27.8 million; the TTM figure through Mar 2026 stood at -$99.9 million (up 10.18% YoY), while the FY2025 annual figure was -$104.1 million, up 4.33% from the prior year.
- Profit After Tax was -$27.8 million for Q1 2026 at Nkarta, down from -$27.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$21.7 million in Q3 2025 to a low of -$33.3 million in Q2 2023.
- Historically, Profit After Tax has averaged -$27.8 million across 5 years, with a median of -$27.8 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax plunged 42.82% in 2022, then advanced 24.92% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$32.6 million in 2022, then grew by 14.82% to -$27.8 million in 2023, then climbed by 6.55% to -$25.9 million in 2024, then decreased by 5.68% to -$27.4 million in 2025, then declined by 1.54% to -$27.8 million in 2026.
- The last three Profit After Tax figures came in at -$27.8 million (Q1 2026), -$27.4 million (Q4 2025), and -$21.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Nkarta | 210.15 Mn | 210.15 Mn | - | -27.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.83 Mn |
| Dec 31, 2025 | -27.41 Mn |
| Sep 30, 2025 | -21.72 Mn |
| Jun 30, 2025 | -22.98 Mn |
| Mar 31, 2025 | -31.98 Mn |
| Dec 31, 2024 | -25.94 Mn |
| Sep 30, 2024 | -28.34 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Mar 31, 2024 | -29.52 Mn |
| Dec 31, 2023 | -27.75 Mn |
| Sep 30, 2023 | -25.65 Mn |
| Jun 30, 2023 | -33.29 Mn |
| Mar 31, 2023 | -30.82 Mn |
| Dec 31, 2022 | -32.58 Mn |
| Sep 30, 2022 | -28.35 Mn |
| Jun 30, 2022 | -26.92 Mn |
| Mar 31, 2022 | -25.99 Mn |
| Dec 31, 2021 | -22.81 Mn |
| Sep 30, 2021 | -22.35 Mn |
| Jun 30, 2021 | -21.54 Mn |